<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02517242</url>
  </required_header>
  <id_info>
    <org_study_id>13-0485</org_study_id>
    <nct_id>NCT02517242</nct_id>
  </id_info>
  <brief_title>Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control</brief_title>
  <official_title>Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic controlCONTROL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, intervention, randomized, phase IV study. Patients will be included
      with 60 years or older, both sexes, with HbA1c &gt;8.5% using oral antidiabetics agents and
      insulin and then we will be randomized by use syringe or pens device to use insulin NPH and
      regular. All patients will receive a blood glucose monitor, lancet tapes, capillary blood
      glucose tests (3 tests/day). HbA1c will be measured at baseline, 3 and 6 months. Patients
      will see monthly.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated Hemoglobin</measure>
    <time_frame>reduction compared to baseline values at six months</time_frame>
    <description>reduction compared to baseline values</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>reduction compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adherence</measure>
    <time_frame>reduction compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of pills, antidiabetics drugs and antihypertensives drugs</measure>
    <time_frame>reduction compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hypoglycemias</measure>
    <time_frame>reduction compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of severe hypoglycemias</measure>
    <time_frame>reduction of the number of patients with this outcome compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of nocturnal hypoglycemias</measure>
    <time_frame>reduction of the number of patients with this outcome compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of asyntomatic hypoglycemias</measure>
    <time_frame>reduction of the number of patients with this outcome compared to baseline values at six months</time_frame>
    <description>Monthly measurements are made</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Pens Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will receive pens device, insulin, blood glucose monitor, lancet tapes, capillary blood glucose tests (3 tests/day). All will be evaluated monthly for six months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Syringe</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All patients will receive syringe to insulin, insulin, blood glucose monitor, lancet tapes, capillary blood glucose tests (3 tests/day). All will be evaluated monthly for six months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pens Device</intervention_name>
    <arm_group_label>Pens Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Syringe</intervention_name>
    <arm_group_label>Syringe</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Monitoring capillary blood glucose with blood glucose monitor, lancet tapes and capillary blood glucose tests (3 tests/day)</intervention_name>
    <arm_group_label>Pens Device</arm_group_label>
    <arm_group_label>Syringe</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sixty years or older

          -  Diabetes type 2 with Glycated Hemoglobin higher than 8.5%

          -  Using or necessity to use insulin

          -  Using syringe to insulin

          -  Using at least one oral antidiabetic

          -  Accept to participate

        Exclusion Criteria:

          -  Glomerular Filtration Rate lower than 30

          -  Considering unfit for self administration of insulin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ticiana da Costa Rodrigues</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Cl√≠nicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rafael Vaz Machry</last_name>
    <phone>(55)05196264337</phone>
    <email>rafael.machry@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rafael Vaz Machry</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Vaz Machry</last_name>
      <phone>(55)5196264337</phone>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2015</study_first_posted>
  <last_update_submitted>August 4, 2015</last_update_submitted>
  <last_update_submitted_qc>August 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Clinicas de Porto Alegre</investigator_affiliation>
    <investigator_full_name>Ticiana da Costa Rodrigues</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

